For the first time in 40 years, the DEA is finds itself facing criticism — from Congress. Read:
Bill Piper, a Drug Policy Alliance lobbyist, said the tides are changing for marijuana policies as lawmakers have begun questioning the DEA’s efforts on the matter.
“For 13 of the 14 years I have worked on this issue, when the DEA came to a hearing, committee members jumped over themselves to cheerlead,” Piper said. “Now the lawmakers are not just asking tough questions, but also getting aggressive with their arguments.”
The tough questions are bipartisan, too, coming from both sides of the aisle and from both sides of the Capitol Building. I can think of a big bowl of alphabet soup’s worth of agencies I’d like to see face similar criticism…
Join the conversation as a VIP Member